You are not dreaming mate!
Tolerance has its end. BOD has changed side, which means they are likely to change again, especially when IER finalize the report.
When they were turned down by Pfizer to waive the consideration, they were somehow humiliated and feeling helpless.
We saw 2 positive news in the week, a good sign for July as it’s becoming more and more possible for IER to increase the valuation.
The selling side has significantly reduced as retailers left. But given time and hope RAP is showing figures or potential, they will be buying back and yes voters will leave then, which make the voting futile.
Things may change overnight, staying positive. Patience will pay us back.
- Forums
- ASX - By Stock
- RAP
- Ann: ResApp receives FDA 510(k) clearance for SleepCheckRx
Ann: ResApp receives FDA 510(k) clearance for SleepCheckRx, page-100
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
GML
Gateway Mining sells WA Eastern Montague gold project to Brightstar for $14M – half of that in shares
TG1
TechGen Metals kicks off airborne geophys survey at Sally Downs copper play – a first for the permit
Add RAP (ASX) to my watchlist
(20min delay)
|
|||||
Last
20.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $176.2M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
RAP (ASX) Chart |
Day chart unavailable